Skip to main content
Livermore
Livermore
ZHEN

Cidara Therapeutics, Inc.

CDTXDelisted Jan 7, 2026
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001610618

Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.

13F holders, Q1 2024

Institutional positions in Cidara Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
−1 vs. Q4 2023
Shares held
22.1M
−1.12M (−4.8%) vs. Q4 2023
Total value
$20.3M
+$1.88M (+10.2%) vs. Q4 2023
New holders
7
9 more added
Sold out
8
13 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 50 institutions
Q1 2021: 62 institutionsQ2 2021: 55 institutionsQ3 2021: 50 institutionsQ4 2021: 53 institutionsQ1 2022: 44 institutionsQ2 2022: 46 institutionsQ3 2022: 42 institutionsQ4 2022: 42 institutionsQ1 2023: 54 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 51 institutionsQ1 2024: 50 institutionsQ2 2024: 26 institutionsQ3 2024: 27 institutionsQ4 2024: 40 institutionsQ1 2025: 46 institutionsQ2 2025: 109 institutionsQ3 2025: 173 institutionsQ4 2025: 255 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2024: $20.3M
Q1 2021: $56.6MQ2 2021: $40.5MQ3 2021: $42.1MQ4 2021: $39.5MQ1 2022: $25.2MQ2 2022: $13.3MQ3 2022: $17.1MQ4 2022: $20.2MQ1 2023: $34.4MQ2 2023: $29.7MQ3 2023: $22.7MQ4 2023: $18.4MQ1 2024: $20.3MQ2 2024: $16.9MQ3 2024: $35.6MQ4 2024: $183.6MQ1 2025: $205.9MQ2 2025: $1.26BQ3 2025: $3.11BQ4 2025: $7.36BQ1 2026: $0Q2 2026: $0
Institutions holding CDTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025255$7.36B
Q3 2025173$3.11B
Q2 2025109$1.26B
Q1 202546$205.9M
Q4 202440$183.6M
Q3 202427$35.6M
Q2 202426$16.9M
Q1 202450$20.3M
Q4 202351$18.4M
Q3 202352$22.7M
Q2 202352$29.7M
Q1 202354$34.4M
Q4 202242$20.2M
Q3 202242$17.1M
Q2 202246$13.3M
Q1 202244$25.2M
Q4 202153$39.5M
Q3 202150$42.1M
Q2 202155$40.5M
Q1 202162$56.6M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding CDTX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc6,861,127$6.31M0.17%00.0%Unchanged
Vanguard Group Inc3,346,260$3.08M0.00%00.0%Unchanged
Renaissance Technologies LLC2,554,973$2.35M0.00%+752,800+41.8%Added
Alethea Capital Management, LLC1,598,492$1.47M1.19%−29,178−1.8%Reduced
Point72 Asset Management, L.P.1,250,000$1.15M0.00%00.0%Unchanged
5AM Venture Management, LLC1,134,511$1.04M0.23%00.0%Unchanged
Geode Capital Management, LLC838,286$771.4K0.00%+32,415+4.0%Added
BlackRock Inc.715,410$658.2K0.00%−222,751−23.7%Reduced
Schonfeld Strategic Advisors LLC552,000$507.8K0.00%−82,900−13.1%Reduced
Gsa Capital Partners LLP456,606$420.0K0.03%−83,840−15.5%Reduced
Monashee Investment Management LLC369,099$339.6K0.04%00.0%Unchanged
Connor, Clark & Lunn Investment Management Ltd.316,835$291.5K0.00%00.0%Unchanged
State Street Corp271,537$249.8K0.00%−15,500−5.4%Reduced
US Bancorp262,072$241.1K0.00%00.0%Unchanged
Tocqueville Asset Management L.P.163,000$150.0K0.00%+68,000+71.6%Added
Northern Trust Corp160,356$147.5K0.00%−218−0.1%Reduced
Jeppson Wealth Management, LLC148,650$136.8K0.05%+6,200+4.4%Added
West Michigan Advisors, LLC135,000$124.2K0.04%+135,000New
Callan Capital, LLC95,169$87.6K0.01%−8,293−8.0%Reduced
Citadel Advisors LLC84,536$77.8K0.00%+84,536New
XTX Topco Ltd79,012$72.7K0.01%−82,046−50.9%Reduced
Raymond James Financial Services Advisors, Inc.77,553$71.3K0.00%−1,314−1.7%Reduced
Two Sigma Investments, LP67,245$61.9K0.00%+67,245New
Pale Fire Capital SE66,549$61.2K0.01%00.0%Unchanged
Bridgeway Capital Management, LLC60,060$55.3K0.00%00.0%Unchanged
FNY Investment Advisers, LLC56,600$52.0K0.03%+56,600New
Advisor Group Holdings, Inc.52,642$48.4K0.00%00.0%Unchanged
Jane Street Group, LLC45,736$42.1K0.00%+31,982+232.5%Added
Mackenzie Financial Corp39,290$36.1K0.00%+14,036+55.6%Added
Legacy Wealth Asset Management, LLC30,000$27.6K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc26,814$24.7K0.00%00.0%Unchanged
Two Sigma Advisers, LP23,900$22.0K0.00%−16,500−40.8%Reduced
Russell Investments Group, Ltd.17,100$15.7K0.00%00.0%Unchanged
Morgan Stanley15,598$14.3K0.00%−5,000−24.3%Reduced
Prudential Financial Inc12,000$11.0K0.00%00.0%Unchanged
Liberty Wealth Management LLC12,000$11.0K0.00%00.0%Unchanged
Pure Financial Advisors, Inc.11,500$10.6K0.00%00.0%Unchanged
Spire Wealth Management10,000$9.20K0.00%+5,029+101.2%Added
Mariner, LLC10,000$9.20K0.00%+10,000New
Tower Research Capital LLC (TRC)9,048$8.32K0.00%−3,373−27.2%Reduced
Pacifica Partners Inc.8,000$5.95K0.00%00.0%Unchanged
UBS Group AG4,695$4.32K0.00%+4,695New
Wetzel Investment Advisors, Inc.4,000$2.89K0.00%00.0%Unchanged
Allworth Financial LP800$7360.00%00.0%Unchanged
Wells Fargo & Company643$5920.00%+10+1.6%Added
JPMorgan Chase & Co451$4150.00%−983−68.5%Reduced
BNP Paribas Arbitrage, SA353$3250.00%00.0%Unchanged
Cubist Systematic Strategies, LLC290$2670.00%+62+27.2%Added
Qube Research & Technologies Ltd52$480.00%00.0%Unchanged
Simplex Trading, LLC525$00.00%+525New
Nantahala Capital Management, LLC0$00.00%−1,546,745−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−126,540−100.0%Sold out
Virtu Financial LLC0$00.00%−95,450−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−36,681−100.0%Sold out
Aveo Capital Partners, LLC0$00.00%−22,502−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−12,886−100.0%Sold out
Bank of America Corp0$00.00%−53−100.0%Sold out
Royal Bank of Canada0$00.00%−246−100.0%Sold out